Computational protein biomarker prediction: a case study for prostate cancer
<p>Abstract</p> <p>Background</p> <p>Recent technological advances in mass spectrometry pose challenges in computational mathematics and statistics to process the mass spectral data into predictive models with clinical and biological significance. We discuss several cla...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-03-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2105/5/26 |
id |
doaj-454f3639d40f4a6e97fcf2233fe1baad |
---|---|
record_format |
Article |
spelling |
doaj-454f3639d40f4a6e97fcf2233fe1baad2020-11-25T00:44:11ZengBMCBMC Bioinformatics1471-21052004-03-01512610.1186/1471-2105-5-26Computational protein biomarker prediction: a case study for prostate cancerAdam Bao-LingDevineni RaghuKasukurti SrinivasPothen AlexNaik Dayanand NWagner MichaelSemmes O JohnWright George L<p>Abstract</p> <p>Background</p> <p>Recent technological advances in mass spectrometry pose challenges in computational mathematics and statistics to process the mass spectral data into predictive models with clinical and biological significance. We discuss several classification-based approaches to finding protein biomarker candidates using protein profiles obtained via mass spectrometry, and we assess their statistical significance. Our overall goal is to implicate peaks that have a high likelihood of being biologically linked to a given disease state, and thus to narrow the search for biomarker candidates.</p> <p>Results</p> <p>Thorough cross-validation studies and randomization tests are performed on a prostate cancer dataset with over 300 patients, obtained at the Eastern Virginia Medical School using SELDI-TOF mass spectrometry. We obtain average classification accuracies of 87% on a four-group classification problem using a two-stage linear SVM-based procedure and just 13 peaks, with other methods performing comparably.</p> <p>Conclusions</p> <p>Modern feature selection and classification methods are powerful techniques for both the identification of biomarker candidates and the related problem of building predictive models from protein mass spectrometric profiles. Cross-validation and randomization are essential tools that must be performed carefully in order not to bias the results unfairly. However, only a biological validation and identification of the underlying proteins will ultimately confirm the actual value and power of any computational predictions.</p> http://www.biomedcentral.com/1471-2105/5/26ANOVA F-statisticB/W ratiobiomarker discoveryfeature (peak) selectionprostate cancerSELD1-TOF mass spectrometrystatistical discrimination methodssupport vector machine. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Adam Bao-Ling Devineni Raghu Kasukurti Srinivas Pothen Alex Naik Dayanand N Wagner Michael Semmes O John Wright George L |
spellingShingle |
Adam Bao-Ling Devineni Raghu Kasukurti Srinivas Pothen Alex Naik Dayanand N Wagner Michael Semmes O John Wright George L Computational protein biomarker prediction: a case study for prostate cancer BMC Bioinformatics ANOVA F-statistic B/W ratio biomarker discovery feature (peak) selection prostate cancer SELD1-TOF mass spectrometry statistical discrimination methods support vector machine. |
author_facet |
Adam Bao-Ling Devineni Raghu Kasukurti Srinivas Pothen Alex Naik Dayanand N Wagner Michael Semmes O John Wright George L |
author_sort |
Adam Bao-Ling |
title |
Computational protein biomarker prediction: a case study for prostate cancer |
title_short |
Computational protein biomarker prediction: a case study for prostate cancer |
title_full |
Computational protein biomarker prediction: a case study for prostate cancer |
title_fullStr |
Computational protein biomarker prediction: a case study for prostate cancer |
title_full_unstemmed |
Computational protein biomarker prediction: a case study for prostate cancer |
title_sort |
computational protein biomarker prediction: a case study for prostate cancer |
publisher |
BMC |
series |
BMC Bioinformatics |
issn |
1471-2105 |
publishDate |
2004-03-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Recent technological advances in mass spectrometry pose challenges in computational mathematics and statistics to process the mass spectral data into predictive models with clinical and biological significance. We discuss several classification-based approaches to finding protein biomarker candidates using protein profiles obtained via mass spectrometry, and we assess their statistical significance. Our overall goal is to implicate peaks that have a high likelihood of being biologically linked to a given disease state, and thus to narrow the search for biomarker candidates.</p> <p>Results</p> <p>Thorough cross-validation studies and randomization tests are performed on a prostate cancer dataset with over 300 patients, obtained at the Eastern Virginia Medical School using SELDI-TOF mass spectrometry. We obtain average classification accuracies of 87% on a four-group classification problem using a two-stage linear SVM-based procedure and just 13 peaks, with other methods performing comparably.</p> <p>Conclusions</p> <p>Modern feature selection and classification methods are powerful techniques for both the identification of biomarker candidates and the related problem of building predictive models from protein mass spectrometric profiles. Cross-validation and randomization are essential tools that must be performed carefully in order not to bias the results unfairly. However, only a biological validation and identification of the underlying proteins will ultimately confirm the actual value and power of any computational predictions.</p> |
topic |
ANOVA F-statistic B/W ratio biomarker discovery feature (peak) selection prostate cancer SELD1-TOF mass spectrometry statistical discrimination methods support vector machine. |
url |
http://www.biomedcentral.com/1471-2105/5/26 |
work_keys_str_mv |
AT adambaoling computationalproteinbiomarkerpredictionacasestudyforprostatecancer AT devineniraghu computationalproteinbiomarkerpredictionacasestudyforprostatecancer AT kasukurtisrinivas computationalproteinbiomarkerpredictionacasestudyforprostatecancer AT pothenalex computationalproteinbiomarkerpredictionacasestudyforprostatecancer AT naikdayanandn computationalproteinbiomarkerpredictionacasestudyforprostatecancer AT wagnermichael computationalproteinbiomarkerpredictionacasestudyforprostatecancer AT semmesojohn computationalproteinbiomarkerpredictionacasestudyforprostatecancer AT wrightgeorgel computationalproteinbiomarkerpredictionacasestudyforprostatecancer |
_version_ |
1725275903495241728 |